Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Diagnostics & Research


Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...

  Jun 01, 2024

Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024

  Jun 01, 2024

New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone)...

  Jun 01, 2024

IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Marinus...

  Jun 01, 2024

IMPORTANT INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims...

  Jun 01, 2024

IMPORTANT INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims...

  Jun 01, 2024

CRUCIAL INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against...

  Jun 01, 2024

Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1...

  Jun 01, 2024

Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01...

  Jun 01, 2024

Pfizer's ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in...

  Jun 01, 2024

IMPORTANT ACTION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CVS...

  Jun 01, 2024

KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free...

  Jun 01, 2024

Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...

  Jun 01, 2024

Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional...

  Jun 01, 2024

Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of...

  Jun 01, 2024

Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with...

  Jun 01, 2024

Class Action Announcement for Akero Therapeutics, Inc. (AKRO): A Securities Fraud Class Action...

  Jun 01, 2024

Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting

  Jun 01, 2024

Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab...

  Jun 01, 2024

SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to...

  Jun 01, 2024

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent...

  Jun 01, 2024

Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting

  Jun 01, 2024

ClearPoint Neuro Announces Full Market Release of SmartFrame OR(TM) and ClearPoint PRISM® 3T...

  Jun 01, 2024

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as...

  Jun 01, 2024

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune

  Jun 01, 2024

Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily...

  Jun 01, 2024

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Teladoc Health

  Jun 01, 2024

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho

  Jun 01, 2024

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari Medical

  Jun 01, 2024

IMPORTANT ACTION ALERT: The Schall Law Firm Encourages Investors in Blueprint Medicines Corporati...

  Jun 01, 2024

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UnitedHealth

  Jun 01, 2024

Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One...

  Jun 01, 2024

Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA

  Jun 01, 2024

Class Action Announcement (GDRX): Kessler Topaz Meltzer & Check, LLP Has Filed A Securities Fraud...

  Jun 01, 2024

IMPORTANT ACTION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against MacroGe...

  Jun 01, 2024

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against...

  Jun 01, 2024

INVESTIGATION PROGRESS REMINDER: The Schall Law Firm Announces it is Investigating Claims Against...

  Jun 01, 2024

IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Allakos...

  Jun 01, 2024

INVESTIGATION PROGRESS ALERT: The Schall Law Firm Announces it is Investigating Claims Against...

  Jun 01, 2024

INVESTIGATION PROGRESS UPDATE: The Schall Law Firm Encourages Investors in Inari Medical, Inc....

  Jun 01, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...

  Jun 01, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...

  Jun 01, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...

  Jun 01, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in...

  Jun 01, 2024

NARI Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Inari Medical, Inc. Investors with...

  Jun 01, 2024

IMPORTANT DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in QuidelOrtho Corporati...

  Jun 01, 2024

CRUCIAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to...

  Jun 01, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against UnitedH...

  Jun 01, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Teladoc...

  Jun 01, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Inari...

  Jun 01, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regenero...

  Jun 01, 2024

FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in Exscientia plc with...

  Jun 01, 2024

More

Agriculture Building Materials Cannabis Chemicals Coal Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Forest Products Healthcare Industrials Metals & Mining Gold Industrial Metals & Minerals Silver Real Estate Steel Technology Utilities

Companies of Interest

Gemina Laboratories Ltd.